160 related articles for article (PubMed ID: 18720701)
1. Development of systemic lupus erythematosus in a patient with rheumatoid arthritis following treatment conversion of infliximab to adalimumab.
Havel J; Aboutalebi S; Doughty L; Wirges M
J Drugs Dermatol; 2008 Aug; 7(8):796-8. PubMed ID: 18720701
[TBL] [Abstract][Full Text] [Related]
2. Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level.
van Rijthoven AW; Bijlsma JW; Canninga-van Dijk M; Derksen RH; van Roon JA
Rheumatology (Oxford); 2006 Oct; 45(10):1317-9. PubMed ID: 16844698
[No Abstract] [Full Text] [Related]
3. Adalimumab-induced lupus erythematosus.
Martín JM; Ricart JM; Alcácer J; Rausell N; Arana G
Lupus; 2008 Jul; 17(7):676-8. PubMed ID: 18625641
[TBL] [Abstract][Full Text] [Related]
4. [Lupus like syndrome induced by treatment with anti TNFalpha (infliximab): report of three cases].
Benucci M; Nenci G; Cappelletti C; Manfredi M
Recenti Prog Med; 2008; 99(7-8):363-6. PubMed ID: 18751615
[TBL] [Abstract][Full Text] [Related]
5. Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab.
Mañosa M; Domènech E; Marín L; Olivé A; Zabana Y; Cabré E; Gassull MA
Gut; 2008 Apr; 57(4):559; author reply 559-60. PubMed ID: 18334664
[No Abstract] [Full Text] [Related]
6. Drug-induced lupus associated with infliximab and adalimumab in an adolescent with Crohn disease.
Zella GC; Weinblatt ME; Winter HS
J Pediatr Gastroenterol Nutr; 2009 Sep; 49(3):355-8. PubMed ID: 19516196
[No Abstract] [Full Text] [Related]
7. Adalimumab-induced lupus erythematosus with central nervous system involvement in a patient with Crohn's disease.
Vannucchi V; Grazzini M; Pieralli F; Giannotta M; Biagioni C; Nozzoli C
J Gastrointestin Liver Dis; 2011 Jun; 20(2):201-3. PubMed ID: 21725519
[TBL] [Abstract][Full Text] [Related]
8. Adalimumab-induced lupus erythematosus.
Al-Niaimi F
Eur J Dermatol; 2009; 19(4):380. PubMed ID: 19451046
[No Abstract] [Full Text] [Related]
9. Is the development of drug-related lupus a contraindication for switching from one TNF alpha inhibitor to another?
Kocharla L; Mongey AB
Lupus; 2009 Feb; 18(2):169-71. PubMed ID: 19151120
[TBL] [Abstract][Full Text] [Related]
10. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey.
De Bandt M; Sibilia J; Le Loët X; Prouzeau S; Fautrel B; Marcelli C; Boucquillard E; Siame JL; Mariette X;
Arthritis Res Ther; 2005; 7(3):R545-51. PubMed ID: 15899041
[TBL] [Abstract][Full Text] [Related]
11. Borreliosis mimicking lupus-like syndrome during infliximab treatment.
Molin S; Ruzicka T; Prinz JC
Clin Exp Dermatol; 2010 Aug; 35(6):631-3. PubMed ID: 20184613
[TBL] [Abstract][Full Text] [Related]
12. Infliximab induced lupus in patients with rheumatoid arthritis.
Elkayam O; Caspi D
Clin Exp Rheumatol; 2004; 22(4):502-3. PubMed ID: 15301255
[No Abstract] [Full Text] [Related]
13. Infliximab-induced SLE-like syndrome involving the lung and pleura.
Diri E; Tello W; Ratnoff WD; Nugent K
Lupus; 2007; 16(9):764-6. PubMed ID: 17728373
[No Abstract] [Full Text] [Related]
14. Pustular psoriasis following treatment of rheumatoid arthritis with TNF-alpha inhibitors.
Egnatios G; Warthan MM; Pariser R; Hood AF
J Drugs Dermatol; 2008 Oct; 7(10):975-7. PubMed ID: 19112764
[No Abstract] [Full Text] [Related]
15. Anti-TNF-alpha-induced systemic lupus syndrome.
Debandt M; Vittecoq O; Descamps V; Le Loët X; Meyer O
Clin Rheumatol; 2003 Feb; 22(1):56-61. PubMed ID: 12605321
[TBL] [Abstract][Full Text] [Related]
16. Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis.
Graninger WB; Hassfeld W; Pesau BB; Machold KP; Zielinski CC; Smolen JS
J Rheumatol; 1991 Oct; 18(10):1621-2. PubMed ID: 1765991
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced lupus after treatment with infliximab in rheumatoid arthritis.
Benucci M; Li Gobbi F; Fossi F; Manfredi M; Del Rosso A
J Clin Rheumatol; 2005 Feb; 11(1):47-9. PubMed ID: 16357696
[TBL] [Abstract][Full Text] [Related]
18. Infliximab-induced lupus or rheumatoid arthritis (RA) overlapping with systemic lupus erythematosus (SLE) unmasked by infliximab.
Novak S; Cikes N
Clin Exp Rheumatol; 2004; 22(2):268. PubMed ID: 15083903
[No Abstract] [Full Text] [Related]
19. Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy.
Damián-Abrego GN; Cabiedes J; Cabral AR
Lupus; 2008 Apr; 17(4):300-4. PubMed ID: 18413411
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of autoantibodies induced by infliximab treatment: two-year follow-up after infliximab discontinuation.
Novak S; Anić B; Anić F; Cerovac M; Cikeš N
Acta Dermatovenerol Croat; 2011; 19(3):156-60. PubMed ID: 21933639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
